JP

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Hong Kong (China) *

Republic of Korea *

all-in-one-crispr1920x640

Literature - Publication Review

All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells

Discover how scientists from TaiRx Inc. and Revvity preclinical services teamed up to explore efficacy improvements for a novel anti-cancer drug in our literature review.

In this literature, you will:

Find out how CRISPR screening can be used to identify key genes and pathways of importance
Learn how the team’s approach was applied to identify robust, actionable hits
See data from a deeper dive analysis into the mTOR pathway

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

営業担当者から連絡を受けることに同意します。

お名前（名）

お名前（姓）

国

メールアドレス

会社名

郵便番号

勤務先電話番号

職種

* が付いているフィールドは入力必須です
お客様は個人データを送信することにより、Revvity Inc. およびその関連会社（以下「当社」）が、当社のプライバシーポリシー（ご覧になるにはこちらをクリック）に従って上記で提供されたお客様の個人データを処理することに同意するものとします。

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells

Download Literature - Publication Review